Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Director departure
CC transcript
|
|
PAR PHARMACEUTICAL COMPANIES, INC. (PRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/21/2015 |
8-K
| Quarterly results |
| 08/06/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
| 05/11/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
| 03/12/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 02/25/2015 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"AMENDMENT NO. 5 AMENDMENT NO. 5, dated as of February 20, 2015 , by and among PAR PHARMACEUTICAL COMPANIES, INC., a Delaware corporation , the Revolving Credit Lenders party hereto, and BANK OF AMERICA, N.A. , as administrative agent under the Credit Agreement, dated as of September 28, 2012 , among the Parent Borrower, PAR PHARMACEUTICAL, INC., a Delaware corporation , SKY GROWTH INTERMEDIATE HOLDINGS II CORPORATION, a Delaware corporation , BANA, as administrative agent under the Loan Documents, Swing Line Lender and L/C Issuer, each lender from time to time party thereto , and the other parties thereto from time to time. Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement. WHEREAS, Section 10.01 of the Credit Agreement...",
"Amendment No. 6 to the Credit Agreement among the Borrowers, Holdings, certain subsidiaries of the Company party thereto, BANA, as administrative agent and BANA, Goldman Sachs Bank USA and Deutsche Bank Securities Inc., as lead arrangers, which amends the Amended Credit Agreement" |
|
| 02/10/2015 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/12/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 09/22/2014 |
8-K
| Other Events |
| 08/11/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 05/14/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 03/18/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 02/20/2014 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...|
Docs:
|
"AMENDMENT NO. 4 AMENDMENT NO. 4, dated as of February 20, 2014 , by and among PAR PHARMACEUTICAL COMPANIES, INC., a Delaware corporation , PAR PHARMACEUTICAL, INC., a Delaware corporation , SKY GROWTH INTERMEDIATE HOLDINGS II CORPORATION, a Delaware corporation , the Subsidiary Guarantors party hereto, BANK OF AMERICA, N.A. , as administrative agent , BANA, Goldman Sachs Bank USA and Deutsche Bank Securities Inc. , as Lead Arrangers under the Credit Agreement, dated as of September 28, 2012 , among the Parent Borrower, the Co-Borrower, Holdings, BANA, as administrative agent under the Loan Documents, Swing Line Lender and L/C Issuer, each lender from time to time party thereto , and the other parties thereto from time to time. Capitalized terms used and not otherwise defined herein shall h...",
"INCREMENTAL TERM B-2 LOAN JOINDER AGREEMENT JOINDER AGREEMENT, dated as of February 20, 2014 , by and among the Incremental Term Lender party hereto , PAR PHARMACEUTICAL COMPANIES, INC. , PAR PHARMACEUTICAL, INC. , the other Loan Parties party hereto, BANK OF AMERICA, N.A. , as Administrative Agent , BANA and Goldman Sachs Bank USA . RECITALS:" |
|
| 02/19/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/29/2014 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 01/21/2014 |
8-K
| Acquisition/merger/asset purchase announced |
| 11/12/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
| 08/28/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 08/27/2013 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 02/11/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/16/2012 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 10/12/2012 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 10/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
|
|
|